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Brainstem and hypothalamic “orexigenic/anorexigenic” networks are thought to maintain
body weight homeostasis in response to hormonal and metabolic feedback from
peripheral sites. This approach has not been successful in managing over- and
underweight patients. It is suggested that concept of homeostasis has been
misinterpreted; rather than exerting control, the brain permits eating in proportion to the
amount of physical activity necessary to obtain food. In support, animal experiments have
shown that while a hypothalamic “orexigen” excites eating when food is abundant, it
inhibits eating and stimulates foraging when food is in short supply. As the physical price
of food approaches zero, eating and body weight increase without constraints. Conversely,
in anorexia nervosa body weight is homeostatically regulated, the high level of physical
activity in anorexia is displaced hoarding for food that keeps body weight constantly low.
A treatment based on this point of view, providing patients with computerized mealtime
support to re-establish normal eating behavior, has brought 75% of patients with eating
disorders into remission, reduced the rate of relapse to 10%, and eliminated mortality.
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INTRODUCTION
The obvious goal of treatment of over- and underweight is to
normalize the weight of the patients and restore their health. We
offer an explanation why current methods fail, and we outline the
rationale for an alternative approach and describe its outcome.
From our perspective, the reason for the limited success
in managing body weight problems is because the concept of
homeostasis as applied to the brain and eating behavior is a
misinterpretation of the suggestion of Bernard (1865), the follow-
up experiments of Cannon (1932), and the synthesis of Stellar
(1954). In addition, most accounts of underweight patients do
not even consider eating behavior (e.g., Boraska et al., 2014). Also,
the cause of undesirable changes in body weight is thought to be
related of a brain dysfunction, although there is no evidence that
this is the case (Södersten et al., 2011).
Eating behavior has evolved to meet the challenge of star-
vation, an efficient foraging strategy has been encouraged, and
satiety has been discouraged (Södersten et al., 2008; McCue,
2012). Further on, eating behavior mediates between the phys-
ical and mental state of the patient (Ioakimidis et al., 2011),
and most neural, endocrine, and behavioral effects are reversible
adaptations to the shortage of food, rather than signs of disease
(Södersten et al., 2008).
OVERWEIGHT
Some aspects of overweight will be considered first, because
overweight is on the extreme opposite of anorexia on the same
behavioral and biochemical continuum (Bergh et al., 2008).
All levels of nearly all societies, from the individual to the
systems of health care and finance, are affected by the prob-
lem of obesity. Human biology has been taken by surprise; we
are not equipped with counter-regulatory mechanisms protecting
us from the medical consequences of overeating and weight
gain. These consequences have been reviewed many times and
one conclusion stands out: most medical effects of obesity are
reversible.
Pharmacological approaches have miniscule effects and
unavoidable, undesirable side effects, which may include changes
in mood and addiction (Poulton and Nanan, 2014; Yanovski
and Yanovski, 2014). And although a minor decrease in body
weight improves the patient’s health, most patients relapse within
a brief period of time (Yanovski and Yanovski, 2014). Not so with
irreversible gastric surgery, which has a much bigger effect, the
improvement of health is unquestionable (Carlsson et al., 2012).
Alas, upon long-term follow-up, the patientsmay relapse into dia-
betic problems even though their weight may not return to its
pre-operative level of obesity (Sjöström et al., 2014). Because sur-
geons cannot possibly operate on all the patients in need, it was
recently suggested that gastric surgery might be replaced by the
mediators of its effects, i.e., the release of bile acids and the emer-
gent improvement of metabolic parameters (Ryan et al., 2014).
Characteristically, the study ended in the exact samemanner as all
other studies on the topic of obesity by “suggesting new targets for
. . . therapeutic interventions.” The same suggestion has emerged
each time when the relatively rare obese genotypes have been dis-
covered (Pearce et al., 2013). Sadly, most of these suggestions have
failed (Troke et al., 2014).
UNDERWEIGHT
The following description of the outcome in anorexia nervosa was
published seven times the last year in the Lancet:
“Anorexia nervosa is characterized by a chronic course that is
refractory to treatment in many patients and has one of the high-
est mortality rates of any psychiatric disorder,” and: “The evidence
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base for anorexia nervosa treatment is meager considering the
extent to which this disorder erodes quality of life and takes far
too many lives prematurely” (Lipsman et al., 2013; Treasure and
Schmidt, 2013; Attia, 2014; Bulik, 2014; Editorial, 2014; Herpertz-
Dahlmann et al., 2014; Zipfel et al., 2014). The same outcome was
described 20 years earlier (Bergh and Södersten, 1998). Clearly,
this field is at a standstill.
Conventional approaches to the management of anorexic
patients rely on assumption that a chronic mental illness
causes anorexia (Wierenga et al., 2014). This hypothesis persists
although interventions targeting mental illness have no effect and
despite the fact that the list of the other counter-arguments is very
long (Bergh et al., 2013). While patients may go into remission
from their anorexic symptoms, they remain symptomatic upon
discharge from standard care, and the majority is reported to
relapse within one year (Bergh et al., 2013). This is why anorexia is
considered a chronic disease, associated with fatalistic views, e.g.,
co-morbidity, relapse, and mortality, which resist counterfactual
scientific evidence (Dar-Nimrod and Heine, 2011).
An attempt at analyzing obesity in a psychiatric, neuro-
science framework was unsuccessful, and therefore not pursued
(Ziauddeen et al., 2012). By contrast, attempts at analyzing
anorexia in the same manner are made repeatedly. The problem
with these studies is that it is not possible to dissociate the state
of the patient from her/his hypothetical mental illness (Wierenga
et al., 2014). Patients may be in remission from anorexia, but
the changes which are found in the brain may be related to
the remaining symptoms, rather than the anorexic symptoms
from which the patients are thought to have recovered (Wierenga
et al., 2014). At present, there are no reports of brain function
in anorexic patients who are in remission from all symptoms,
although an excellent study came pretty close (Cowdrey et al.,
2011).
Unlike the rare obese genotypes which have been found (e.g.,
Pearce et al., 2013), no anorexic genotype has been demonstrated.
Hence the reticence in recent publications of the “possible role
of known or putatively functional markers in genes regulating
appetite and weight” in anorexia and bulimia, which “If repli-
cated, . . .may serve as an important first step toward gaining a
better understanding of weight regulation in eating disorders”
(Yilmaz et al., 2014), and “Findings from candidate gene studies
of [anorexia nervosa] resemble those for most complex biomedi-
cal diseases—initial intriguing findings diminished by the absence
of rigorous replication” (Boraska et al., 2014).
We suggest that analyses of both obesity and anorexia fail
because the biology of eating behavior is not taken into consid-
eration.
HOMEOSTASIS
Bernard (1865) first suggested the existence of internal counter-
regulatory mechanisms protecting against external variation,
keeping the internal milieu constant. Cannon (1932) developed
Bernard’s idea and coined the term “homeostasis” to designate
“a condition that may vary, but which is relatively constant.”
It is important to note that Cannon’s experiments were based
on the study of depletion (Södersten et al., 2008). Interestingly,
however, he suggested that: “Cooperating with hunger and thirst
in a way not yet clearly defined is the sensation of having
had enough. Protection of the organism of being overstocked
with food and water is thus obtained.” However, Cannon did
not test the hypothesized satiety mechanism and if he had, he
had very likely falsified it. In parallel, Stellar (1954) launched
the dual center theory according to which eating behavior is
controlled by the activity of anatomically separable centers in
the hypothalamus which excite or inhibit eating as a result of
feedback from peripheral endocrine and/or metabolic events.
Stellar’s (1954) theory has permeated all research in the area,
although excitation and inhibition of eating are now thought to
be chemically mediated by partially separable neural networks
extending from the brainstem to the forebrain (Grill and Hayes,
2012).
However, obesity keeps increasing (Ng et al., 2014), provid-
ing compelling evidence against the existence of internal satiety
mechanisms protecting us from being overstocked. Instead, it was
recently pointed out that eating too much is a normal response
to a change in the environment, i.e., the availability of energy-
dense foods at a low economic and physical price (Swinburn et al.,
2011). These external influences can be added to the concept of
homeostasis as follows.
THE HUMAN HOMEOSTATIC PHENOTYPE
Shortage of food is the main challenge in evolution and animals,
including humans, have developed sophisticated strategies to for-
age for food (McCue, 2012). Addition of this decisive biological
fact to the homeostatic framework has increased our understand-
ing of how the brain is engaged in eating behavior. This analysis
started by the observation that rats of both sexes can show con-
summatory ingestive and sexual behavior simultaneously (Kaplan
et al., 1992). This should not surprise as these kinds of behavior
engage different muscles. By contrast, appetitive behavior engages
the same muscles independent upon what reward is going to be
consumed. Interestingly, activation of appetitive sexual behav-
ior blocks appetitive ingestive behavior (Kaplan et al., 1992). A
series of experiments revealed that one hypothesized hypothala-
mic “orexigen,” neuropeptide tyrosine (NPY), exerts the opposite
effect by selectively stimulating appetitive ingestive behavior at
the expense of eating, and simultaneously blocking appetitive sex-
ual behavior. Thus, infusion of NPY into the brain has a highly
specific behavioral effect, changing the rat’s preference from a
sexual to a food reward (Ammar et al., 2000). Further on, decreas-
ing of the availability of food causes an increase in running, a
decrease in eating, and an increase in the synthesis of NPY in
the hypothalamus, in a model of food foraging (Nergårdh et al.,
2007). Infusion of NPY into the brain replicates the effects on
running and eating (Nergårdh et al., 2007).
These results implicate NPY as a mediator of foraging, rather
than eating, in an evolutionary conserved neuroendocrine system
engaging the NPY Y1 receptor (Lecklin et al., 2003). In the frame-
work of homeostasis, the synthesis of hypothalamic “orexigens”
are controlled by leptin and in line with the present perspec-
tive, leptin selectively reduces foraging for food in the model
discussed above (Ribeiro et al., 2011). This new role of brain mes-
sengers, previously thought of as “orexigens,” has been confirmed
(Bartness et al., 2011).
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Thus, foraging for food increases and eating decreases when
food is in short supply (Södersten et al., 2008; Bartness et al.,
2011). Conversely, eating without biological constraints is the
normal response to an abundance of inexpensive food (Swinburn
et al., 2011).
This allows definition of a human homeostatic phenotype,
i.e., maintenance of a stable, healthy, low body weight when the
physical price of the food is high. As that price approaches zero,
eating and body weight increase passively. Most human genotypes
allow this development as testified by the marked increase in body
weight in many societies, with some variation dependent upon
e.g., ethnicity (Ng et al., 2014; Sellayah et al., 2014).
ANOREXIA NERVOSA, CAUSE, AND TREATMENT
Anorexia nervosa conforms to the human homeostatic pheno-
type described above, the high level of physical activity, and the
retained capacity to eat a normal amount of food is particularly
important in the present context (Södersten et al., 2008). It is long
recognized that the “endocrinology of anorexia” is a reversible
consequence of starvation (Södersten et al., 2008), and although
“an underlying mental disorder” is thought to cause of anorexia
(Wierenga et al., 2014), the arguments against this point of view
are overwhelming (Bergh et al., 2013). The evidence that any
healthy individual will develop all symptoms of anorexia nervosa
in response to a reduction in food intake is compelling (Keys et al.,
1950; Södersten et al., 2008).
Because of the importance of starvation and foraging in
human evolution we should therefore “anticipate that genes that
enable humans to tolerate prolonged starvation will be found.
The search for such genes should, however, probably focus on
other phenotypes than anxiety, e.g., those that are capable of a
high level of physical activity because of their obvious survival
value (Diamond, 2003; Chakravarthy and Booth, 2004). Anorexic
patients are likely to have such genes, which should not be labeled
‘disease’ genes” (Södersten et al., 2006). This hypothesis implies
that anorexics are resistant to starvation, not that they are in a
“normal” condition.
Implemented clinically over the last 20 years, the present
perspective relies on a neurobiological framework according to
which anorexia nervosa is caused by dieting, activating release
of dopamine from limbic terminals of mesencephalic cellbodies,
inducing a feeling of “reward,” and encouraging the patient to
continue eating less food (Bergh and Södersten, 1996). Dieting
also engages the noradrenergic cell bodies of the locus coeruleus,
which are part of the brain’s system for attention and so anorexia
is maintained by conditioning to the cues which provided reward
in the first place. Anorexia is the prototypical eating disorder,
the other disorders are different expressions of the same problem
(Bergh et al., 2002). This framework has been updated (Södersten
et al., 2008), including a description of how disordered eating
behavior causes mental change (Ioakimidis et al., 2011).
The main intervention is the restoration of normal eating
behavior using mealtime visual feedback on a computer screen.
The treatment has been described many times, strict criteria of
remission must be met, patients in remission display none of the
symptoms diagnosed at admission (see Bergh et al., 2013). A ran-
domized controlled trial showed that the treatment has a strong
effect, the rate of remission was estimated to be 75% in a group of
168 patients, the time to remission was about 12 months and the
rate of relapse was about 10% in 83 patients who were followed-
up over five years (Bergh et al., 2002). 1428 patients were treated
between 1993 and 2011 replicating the same outcome in six differ-
ent clinics in four countries, and with no mortality (Bergh et al.,
2013).
This outcome was obtained despite the fact that 251 patients
were severely ill and required in-patient treatment, and despite
the fact that the Body Mass Index (BMI) of the 571 anorexic
patients (14.9; quartile range 13.8–16.1 kg/m2) was very low at
admission and normal at remission. This BMI is much lower than
the BMI (16.7; SD 0.1) of 242 patients in a recent report (Zipfel
et al., 2014). Yet, at 12 months of follow-up, 30% of the patients in
that report had dropped out and, although their body weight had
increased, none of the patients had a normal BMI (Zipfel et al.,
2014).
The same treatment has been adapted for normalizing eating
behavior and improving the health of obese children (Ford et al.,
2010), supporting the hypothesis that under- and overweight are
expressions of the same problem (Bergh et al., 2008).
DISRUPTION OF HOMEOSTASIS?
The present perspective differs from standard psychiatric
approaches in most aspects, and most importantly in outcome.
However, it also departs from the theme of this research topic in
that anorexia nervosa is considered an example of homeostasis.
Thus, food intake and physical activity are in balance, maintain-
ing a constant low body weight. However, anorexics are captured
in an undesirable state, unable to escape, they need to re-learn
how to eat normally. In this lies the opportunity of developing
new methods to treat the patients.
On the hypothesis that dieting is the main cause for anorexia,
it is noteworthy that young women eat less food for lunch after
skipping dinner the day before and that k = the rate at which
their speed of eating decreases over the course of the meal mea-
sured in their pre-deprivation eating behavior determines the size
of the effect (Zandian et al., 2011). Food intake is modeled by y=
kx2 + lx; where y is food intake, k is as just defined, l is the ini-
tial speed of eating, and x is time. The more negative the value
of k, the better the compensation for a brief period of fasting
(Figure 1A). Dieting increases the value of k and as k → 0, i.e.,
as the speed of eating becomes constant, women are less able to
adapt their food intake to challenges such as having to eat slowly,
they actually eat less food yet experience a higher level of sati-
ety, thereby approaching the anorexic pattern of eating (Zandian
et al., 2009). And when experimentally challenged to eat quickly,
they approach the behavior of patients with Binge EatingDisorder
(Figure 1B; Ioakimidis et al., 2009). Thus, dieting increases the
linearity of eating, exacerbating the risk for losing control over
food intake. However, the change in food intake can be reversed
by visual feedback on howmuch to eat over the course of the meal
(Figure 1C). Therefore, the biological changes which occur after
a brief period of deprivation do not prevent women from main-
taining their normal level of food intake (Zandian et al., 2011).
Note the marked sex difference in the response to fasting; while
women eat less food, men eat more (Zandian et al., 2011), an
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FIGURE 1 | (A) Effect of omitted eating dinner on food intake at lunch in 20
women as a function of deceleration (k) of the speed of eating in their
un-deprived condition. y = kx2 + lx; y = food intake, k = deceleration, i.e.,
rate at which the speed of eating changes over the course of the meal,
l = initial speed of eating and x = time. The k-values are from a lunch in the
un-deprived condition and the change in food intake is expressed as the
percent of that lunch after the women. (B) Cumulative food intake in women
who ate at a nearly constant rate (k ∼ 0, n = 16) and female patients with
anorexia nervosa (AN, n = 16) or Binge Eating Disorder (BED, n = 12). The
women were challenged to eat a lunch at an increased (ER+) or decreased
(ER−) speed. The end of the uninterrupted lines indicates the point in time
when the subjects stopped eating; the dashed continuation of the line
indicates the extrapolation of the modeled curve. (C) Food intake at lunch in
13 women and 9 men in their un-deprived condition (Ctr), after omitting
dinner the day before lunch without (− Fasting) or with (− Feedback) visual
feedback on how to eat. We thank Elsevier for permission to reproduce (A,C)
from Zandian et al. (2011) and Springer Science+Business Media for
permission to reproduce (B) from Ioakimidis et al. (2009).
effect likely related to the fact that 95% of anorexic patients are
female.
CONCLUDING REMARK
Based on the present perspective, we predicted that the phar-
macological project for weight control will fail (Södersten et al.,
2006). How could it succeed considering that neural networks
permit excessive eating when eating is easy but not when eating
requires an effort? A simple change in the environment turns an
“orexigen” into an “anorexigen” (Ammar et al., 2000; Nergårdh
et al., 2007). From our perspective, eating behavior is the cause of
the problems of body weight, not a mere product of the activity
of the brain. In support, we found that an experimental change
in eating behavior among obese children brought an “orexigen,”
ghrelin, under control while improving the health of the children
(Ford et al., 2010; Galhardo et al., 2012). This is just one instance
of behavioral control of the endocrine system, which is long
known in experimental endocrinology (e.g., Lehrman, 1961). We
are presently exploring the possibility of using the approach to
prevent the problems of body weight.
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